Cancer Research Technology and Nuevolution Sign Multi-Target Deal

News   Nov 04, 2013

 
Cancer Research Technology and Nuevolution Sign Multi-Target Deal
 
 
 

RELATED ARTICLES

New Partnership to Provide Bioanalytical and DMPK Services

News

Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.

READ MORE

Toothpaste Ingredient Could Help Fight Drug-Resistant Malaria

News

An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of malaria parasite that have grown resistant to one of the currently-used drugs.

READ MORE

Single Blood Test 'CancerSEEK' Screens for Eight Cancer Types

News

Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE